Multisystem inflammatory syndrome in children and Kawasaki disease : a critical comparison
© 2021. Springer Nature Limited..
Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the more severe coronavirus disease 2019 (COVID-19) described in adults. However, SARS-CoV-2 is also associated with a widely reported but poorly understood paediatric systemic vasculitis. This multisystem inflammatory syndrome in children (MIS-C) has features that overlap with myocarditis, toxic-shock syndrome and Kawasaki disease. Current evidence indicates that MIS-C is the result of an exaggerated innate and adaptive immune response, characterized by a cytokine storm, and that it is triggered by prior SARS-CoV-2 exposure. Epidemiological, clinical and immunological differences classify MIS-C as being distinct from Kawasaki disease. Differences include the age range, and the geographical and ethnic distribution of patients. MIS-C is associated with prominent gastrointestinal and cardiovascular system involvement, admission to intensive care unit, neutrophilia, lymphopenia, high levels of IFNγ and low counts of naive CD4+ T cells, with a high proportion of activated memory T cells. Further investigation of MIS-C will continue to enhance our understanding of similar conditions associated with a cytokine storm.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Nature reviews. Rheumatology - 17(2021), 12 vom: 29. Dez., Seite 731-748 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sharma, Chetan [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 03.12.2021 Date Revised 28.10.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41584-021-00709-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM332547140 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM332547140 | ||
003 | DE-627 | ||
005 | 20231225215807.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41584-021-00709-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1108.xml |
035 | |a (DE-627)NLM332547140 | ||
035 | |a (NLM)34716418 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sharma, Chetan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multisystem inflammatory syndrome in children and Kawasaki disease |b a critical comparison |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.12.2021 | ||
500 | |a Date Revised 28.10.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021. Springer Nature Limited. | ||
520 | |a Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the more severe coronavirus disease 2019 (COVID-19) described in adults. However, SARS-CoV-2 is also associated with a widely reported but poorly understood paediatric systemic vasculitis. This multisystem inflammatory syndrome in children (MIS-C) has features that overlap with myocarditis, toxic-shock syndrome and Kawasaki disease. Current evidence indicates that MIS-C is the result of an exaggerated innate and adaptive immune response, characterized by a cytokine storm, and that it is triggered by prior SARS-CoV-2 exposure. Epidemiological, clinical and immunological differences classify MIS-C as being distinct from Kawasaki disease. Differences include the age range, and the geographical and ethnic distribution of patients. MIS-C is associated with prominent gastrointestinal and cardiovascular system involvement, admission to intensive care unit, neutrophilia, lymphopenia, high levels of IFNγ and low counts of naive CD4+ T cells, with a high proportion of activated memory T cells. Further investigation of MIS-C will continue to enhance our understanding of similar conditions associated with a cytokine storm | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
700 | 1 | |a Ganigara, Madhusudan |e verfasserin |4 aut | |
700 | 1 | |a Galeotti, Caroline |e verfasserin |4 aut | |
700 | 1 | |a Burns, Joseph |e verfasserin |4 aut | |
700 | 1 | |a Berganza, Fernando M |e verfasserin |4 aut | |
700 | 1 | |a Hayes, Denise A |e verfasserin |4 aut | |
700 | 1 | |a Singh-Grewal, Davinder |e verfasserin |4 aut | |
700 | 1 | |a Bharath, Suman |e verfasserin |4 aut | |
700 | 1 | |a Sajjan, Sujata |e verfasserin |4 aut | |
700 | 1 | |a Bayry, Jagadeesh |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature reviews. Rheumatology |d 2009 |g 17(2021), 12 vom: 29. Dez., Seite 731-748 |w (DE-627)NLM187559821 |x 1759-4804 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2021 |g number:12 |g day:29 |g month:12 |g pages:731-748 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41584-021-00709-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2021 |e 12 |b 29 |c 12 |h 731-748 |